Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.82 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-19217.1Germany
A.30NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
A.30NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.36.35NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.36.35NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AY.23.1 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.23.1 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.466.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.466.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.13NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.13NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
Q.8 (Alpha)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Q.8 (Alpha)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AY.122.1 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.122.1 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.3.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.3.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AY.5.6 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.5.6 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.440NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.440NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.1.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBC.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBC.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
Q.2 (Alpha)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Q.2 (Alpha)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BL.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BL.1.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
M.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
M.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
C.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
C.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BN.1.5.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BN.1.5.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.66NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.66NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.485NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.485NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
CP.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CP.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.177.73NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.177.73NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AY.112.2 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.112.2 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.2.36NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.5.2.36NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BV.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BV.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BF.26NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used